ARLENA GRAYS: Open Payments
NPI 1073092797 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,134 in 93 payments from 19 companies in 2025. Trend: 2023 $1,970 · 2024 $1,971 · 2025 $2,134
Food & beverage: $2,134
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $570 |
| ABBVIE INC. | 26 | $419 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $258 |
| Phathom Pharmaceuticals, Inc. | 4 | $175 |
| Braintree Laboratories, Inc. | 6 | $125 |
| GENZYME CORPORATION | 4 | $116 |
| Madrigal Pharmaceuticals | 5 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Lilly USA, LLC | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
Products named: TREMFYA, RINVOQ, ENTYVIO, VOQUEZNA, SUTAB, DUPIXENT, LINZESS, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
